Search Result

Results for "

L-Valine

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ADC Linker (2) Akt (15) Amino Acid Derivatives (19) Aminopeptidase (1) Angiotensin Receptor (1) Arginase (15) ATP Synthase (3) Bacterial (15) Biochemical Assay Reagents (3) Drug Derivative (1) Drug Intermediate (4) Endogenous Metabolite (12) HBV (1) Isotope-Labeled Compounds (25) Oligopeptide Cotransporter (1) Reference Standards (5) Ser/Thr Protease (1)
By Research Areas:	Cancer (4) Endocrinology (1) Infection (19) Inflammation/Immunology (1) Metabolic Disease (11) Neurological Disease (3)
Oligonucleotides:	Solubilizing Agents (1) Freeze-drying Protective Agents (1)

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Natural
Products

Isotope-Labeled Compounds

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-N0717

*L-Valine* 5 Publications Verification (S)-Valine	Bacterial Arginase Akt	Infection
L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-20336

Mc-Val-Cit-PABC-PNP Maximum Cited Publications 6 Publications Verification Maleimidocaproyl-L-Valine-L-citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate	ADC Linker	Others Inflammation/Immunology Cancer
Mc-Val-Cit-PABC-PNP is a cathepsin cleavable linker for antibody-drug conjugates (ADCs) which couples the antibody element to the effecting compound. Mc-Val-Cit-PABC-PNP can be used in the synthesis of ADCs .

HY-I1124

L-Valine-d8 1 Publications Verification L-Valine-2,3,4,4,4,5,5,5-d₈	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine-d₈ is a deuterated form of L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-I1111

Fmoc-L-Val-OH FMOC-L-Valine; Fmoc-Valine	Amino Acid Derivatives	Others
Fmoc-L-Val-OH is a valine derivative .

HY-113126

3-Hydroxyisobutyric acid	Endogenous Metabolite ATP Synthase	Neurological Disease Metabolic Disease
3-Hydroxyisobutyric acid is an intermediate in the metabolic pathways of L-valine and thymine, and can be found in urine. 3-Hydroxyisobutyric acid is a secreted mediator of endothelial cell fatty acid transport and insulin resistance. 3-Hydroxyisobutyric acid can also inhibit key enzymes of energy metabolism in the cerebral cortex of young rats. The levels of 3-Hydroxyisobutyric acid are closely related to various diseases such as 3-hydroxyisobutyric aciduria, diabetes, and ketoacidosis .

HY-N0717A

D-Valine (R)-Valine	Endogenous Metabolite	Infection Metabolic Disease
D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid.

HY-W007035

H-Val-Ala-OH 1 Publications Verification Valyl-alanine	Endogenous Metabolite Amino Acid Derivatives	Metabolic Disease
H-Val-Ala-OH (Valyl-alanine) is a dipeptide formed from L-Valine and L-Alanine residues. H-Val-Ala-OH has a role as a metabolite and also has a bitter taste .

HY-N0717R

L-Valine (Standard) (S)-Valine (Standard)	Reference Standards Arginase Akt Bacterial	Infection
L-Valine (Standard) ((S)-Valine (Standard)) is the analytical standard of L-Valine (HY-N0717). This product is intended for research and analytical applications. L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S6

L-Valine-13C5 (S)-Valine-¹³C₅	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine- ¹³C₅ ((S)-Valine- ¹³C₅) is the ¹³C-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-W002300

Boc-L-Valine 1 Publications Verification	Amino Acid Derivatives	Others
Boc-L-Valine is a valine derivative .

HY-N0717S4

L-Valine-1-13C (S)-Valine-1-¹³C	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine-1- ¹³C ((S)-Valine-1- ¹³C) is the ¹³C-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-W016785

Glycyl-L-valine	Biochemical Assay Reagents	Others
Glycyl-L-valine is an organic dipeptide composed of glycine and L-valine .

HY-20561

N-Methyl-L-valine	Amino Acid Derivatives	Others
N-Methyl-L-valine is a valine derivative .

HY-P0108

Angiotensin II 5-valine Valine angiotensin II; 5-L-Valine angiotensin II	Angiotensin Receptor	Endocrinology Cancer
Angiotensin II 5-valine is an agonist of angiotensin receptor.

HY-N0717S

L-Valine-15N (S)-Valine-¹⁵N	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine- ¹⁵N ((S)-Valine- ¹⁵N) is the ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S1

L-Valine-13C5,15N (S)-Valine-¹³C₅,¹⁵N	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine- ¹³C₅, ¹⁵N ((S)-Valine- ¹³C₅, ¹⁵) is the ¹³C- and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-126584

H-Val-Val-OH Val-Val	Drug Intermediate Oligopeptide Cotransporter	Others
H-Val-Val-OH (Val-Val) is a stereochemistry-dependent substrate and inhibitor of apical oligopeptide transporters. H-Val-Val-OH undergoes apical intracellular accumulation in human intestinal cells via carrier-mediated transport, and inhibits the uptake of Cephalexin (HY-B0200) through interaction with transporters. Substitution of L-valine with D-valine in H-Val-Val-OH abolishes its binding ability to apical oligopeptide transporters .

HY-W008733

L-Phenylalanyl-L-valine L-Phe-L-Val; Phe-Val; H-Phe-Val-OH	Amino Acid Derivatives	Others
L-Phenylalanyl-L-valine (L-Phe-L-Val) is a valine derivative .

HY-W008753

Z-L-Val-OH N-Cbz-L-Valine	Biochemical Assay Reagents Drug Intermediate Amino Acid Derivatives	Infection
Z-L-Val-OH (N-Cbz-L-valine) is an amino acid derivative and key intermediate in organic synthesis. Z-L-Val-OH can be used in the synthesis of anti-cytomegalovirus compounds and peptide inhibitors of human spleen plasminogen activator (SFP) and human leukocyte elastase-like protease (ELP) .

HY-P2768

Leucine dehydrogenase, Microorganism LDH, EC 1.4.1.9	Endogenous Metabolite	Metabolic Disease
Leucine dehydrogenase, Microorganism (EC 1.4.1.9) can be purified from Bacillus spheroides. Leucine dehydrogenase catalyzed the oxidative deamination of L-leucine, L-valine, L-isoleucine, L-norvaline, L-alpha-aminobutyrate, and L-norleucine, and the reductive amination of their keto analogues .

HY-41051

(2S)-2-[[(tert-Butoxy)carbonyl](methyl)amino]-3-methylbutanoic acid N-tert-Butoxycarbonyl-N-methyl-L-Valine; N-tert-Butoxycarbonyl-N-methylValine	Amino Acid Derivatives	Others
(2S)-2-[[(tert-Butoxy)carbonyl](methyl)amino]-3-methylbutanoic acid is a valine derivative .

HY-78733

*N-Fmoc-L-valine* N-succinimidyl ester**	Amino Acid Derivatives	Others
N-Fmoc-L-valine N-succinimidyl ester is a valine derivative .

HY-129263

L-Isoleucyl-L-valine Ile-Val	Ser/Thr Protease	Cancer
L-Isoleucyl-L-valine (Ile-Val) is a dipeptide that induces the bovine trypsinogen-trypsin transition .

HY-W048831

(tert-Butoxycarbonyl)-L-valyl-L-valine	Amino Acid Derivatives	Others
(tert-Butoxycarbonyl)-L-valyl-L-valine is a valine derivative .

HY-W011722

N-((Benzyloxy)carbonyl)-N-methyl-L-valine	Amino Acid Derivatives	Others
N-((Benzyloxy)carbonyl)-N-methyl-L-valine is a valine derivative .

HY-N0717AS

*D-Valine-d8* (R)-Valine-d₈	Isotope-Labeled Compounds Endogenous Metabolite	Metabolic Disease
D-Valine-d₈ is the deuterium labeled D-Valine. D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid.

HY-W007035R

H-Val-Ala-OH (Standard) Valyl-alanine (Standard)	Reference Standards Endogenous Metabolite Amino Acid Derivatives	Metabolic Disease
H-Val-Ala-OH (Valyl-alanine) is a dipeptide formed from L-Valine and L-Alanine residues. H-Val-Ala-OH has a role as a metabolite and also has a bitter taste .

HY-W013751

Fmoc-Gly-Val-OH N-Fmoc-glycyl-L-Valine	Drug Intermediate	Others
Fmoc-Gly-Val-OH (N-Fmoc-glycyl-L-valine) is a glycyl valine derivative, can be used for the synthesis of drugs or other compounds .

HY-I1111S

Fmoc-L-Val-OH-d8 FMOC-L-Valine-d₈; Fmoc-Valine-d₈	Isotope-Labeled Compounds Amino Acid Derivatives	Others
Fmoc-L-Val-OH-d₈ is a deuterium labeled Fmoc-L-Val-OH (HY-I1111). Fmoc-L-Val-OH is a kind of protect amino acids .

HY-136614

H-Val-βNA L-Valine β-naphthylamide	Aminopeptidase	Others
H-Val-βNA (L-Valine β-naphthylamide) can be used as an aminopeptidase and a Valine arylamidase substrate .

HY-I1111S2

Fmoc-L-Val-OH-13C5,15N FMOC-L-Valine-¹³C₅,¹⁵N; Fmoc-Valine-¹³C₅,¹⁵N	Isotope-Labeled Compounds Amino Acid Derivatives	Others
Fmoc-L-Val-OH- ¹³C₅, ¹⁵N is a ¹⁵N-labeled and ¹³C-labled Fmoc-L-Val-OH (HY-I1111). Fmoc-L-Val-OH is a valine derivative .

HY-W002300S

*Boc-L-Valine-d8*	Isotope-Labeled Compounds	Others
Boc-L-Valine-d₈ is the deuterium labeled Boc-L-Valine .

HY-N0717AR

*D-Valine* (Standard)** (R)-Valine (Standard)	Reference Standards Endogenous Metabolite	Infection Metabolic Disease
D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid.

HY-119414

N,N-Dimethyl-L-valine L-N,N-DimethylValine	Drug Intermediate	Others
N,N-Dimethyl-L-valine (L-N,N-Dimethylvaline) is a synthetic intermediate useful for pharmaceutical synthesis.

HY-178305S

L-Valine-d	Isotope-Labeled Compounds Bacterial Arginase Akt	Infection
L-Valine-d is the deuterium labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S8

L-Valine-d1 (S)-Valine-d₁	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine-d₁ ((S)-Valine-d₁) is the deuterium labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S5

L-Valine-2-13C (S)-Valine-¹³C	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine-2- ¹³C ((S)-Valine-2- ¹³C) is the ¹³C-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S9

L-Valine-15N,d8 (S)-Valine-¹⁵N,d₈	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine- ¹⁵N,d₈ ((S)-Valine- ¹⁵N,d₈) is the deuterium and ¹⁵N labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S7

L-Valine-1-13C,15N (S)-Valine-1-¹³C,¹⁵N	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine-1- ¹³C, ¹⁵N ((S)-Valine-1- ¹³C, ¹⁵N) is the ¹³C- and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S2

L-Valine-13C5,15N,d8 (S)-Valine-¹³C₅,¹⁵N,d₈	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine- ¹³C₅, ¹⁵N,d₈ ((S)-Valine- ¹³C₅, ¹⁵N,d₈) is the deuterium, ¹³C-, and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S3

L-Valine-13C5,15N,d2 (S)-Valine-¹³C₅,¹⁵N,d₂	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine- ¹³C₅, ¹⁵N,d₂ ((S)-Valine- ¹³C₅, ¹⁵N,d₂) is the deuterium, ¹³C-, and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-113126R

3-Hydroxyisobutyric acid (Standard)	Endogenous Metabolite ATP Synthase Reference Standards	Neurological Disease Metabolic Disease
3-Hydroxyisobutyric acid (Standard) is the analytical standard of 3-Hydroxyisobutyric acid. This product is intended for research and analytical applications. 3-Hydroxyisobutyric acid is an important interorgan metabolite, an intermediate in the pathways of l-valine and thymine and a good gluconeogenic substrate.

HY-113126A

3-Hydroxyisobutyric acid sodium	Endogenous Metabolite ATP Synthase	Neurological Disease Metabolic Disease
3-Hydroxyisobutyric acid sodium is an intermediate in the metabolic pathways of L-valine and thymine, and can be found in urine. 3-Hydroxyisobutyric acid sodium is a secreted mediator of endothelial cell fatty acid transport and insulin resistance. 3-Hydroxyisobutyric acid sodium can also inhibit key enzymes of energy metabolism in the cerebral cortex of young rats. The levels of 3-Hydroxyisobutyric acid sodium are closely related to various diseases such as 3-hydroxyisobutyric aciduria, diabetes, and ketoacidosis .

HY-W016785R

*Glycyl-L-valine* (Standard)**	Reference Standards Endogenous Metabolite	Others
Glycyl-L-valine is a dipeptide that contains glycine and valine.

HY-W048828

((Benzyloxy)carbonyl)-L-alanyl-L-valine	Amino Acid Derivatives	Others
((Benzyloxy)carbonyl)-L-alanyl-L-valine is a valine derivative .

HY-I1111S4

Fmoc-L-Val-OH-15N FMOC-L-Valine-¹⁵N; Fmoc-Valine-¹⁵N	Isotope-Labeled Compounds Amino Acid Derivatives	Others
Fmoc-L-Val-OH- ¹⁵N is a ¹⁵N-labeled Fmoc-L-Val-OH (HY-I1111). Fmoc-L-Val-OH is a valine derivative .

HY-I1111S1

Fmoc-L-Val-OH-1-13C FMOC-L-Valine-¹³C; Fmoc-Valine-¹³C	Isotope-Labeled Compounds Amino Acid Derivatives	Others
Fmoc-L-Val-OH-1- ¹³C is a ¹³C-labeled Fmoc-L-Val-OH (HY-I1111). Fmoc-L-Val-OH is a valine derivative .

HY-178304S

L-Valine-d7	Isotope-Labeled Compounds Bacterial Arginase Akt	Infection
L-Valine-d₇ is the deuterium labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-I1111S3

Fmoc-L-Val-OH-13C5 FMOC-L-Valine-¹³C₅; Fmoc-Valine-¹³C₅	Isotope-Labeled Compounds Amino Acid Derivatives	Others
Fmoc-L-Val-OH- ¹³C₅ is a ¹³C-labeled Fmoc-L-Val-OH (HY-I1111). Fmoc-L-Val-OH is a valine derivative .

HY-W007035S

H-Val-Ala-OH-13C5,15N TFA Valyl-alanine-13C5,15N TFA	Isotope-Labeled Compounds Endogenous Metabolite Amino Acid Derivatives	Metabolic Disease
H-Val-Ala-OH- ¹³C₅, ¹⁵N (Valyl-alanine- ¹³C₅, ¹⁵N) TFA is the ¹³C- and ¹⁵N-labeled H-Val-Ala-OH (HY-W007035). H-Val-Ala-OH (Valyl-alanine) is a dipeptide formed from L-Valine and L-Alanine residues. H-Val-Ala-OH has a role as a metabolite and also has a bitter taste .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N0717

*L-Valine* 5 Publications Verification (S)-Valine	Classification of Application Fields Other Diseases Amino acids Endogenous metabolite Disease Research Fields Source Classification	Bacterial Arginase Akt
L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-113126

3-Hydroxyisobutyric acid	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Other Diseases Endogenous metabolite Disease Research Fields Source Classification	Endogenous Metabolite ATP Synthase
3-Hydroxyisobutyric acid is an intermediate in the metabolic pathways of L-valine and thymine, and can be found in urine. 3-Hydroxyisobutyric acid is a secreted mediator of endothelial cell fatty acid transport and insulin resistance. 3-Hydroxyisobutyric acid can also inhibit key enzymes of energy metabolism in the cerebral cortex of young rats. The levels of 3-Hydroxyisobutyric acid are closely related to various diseases such as 3-hydroxyisobutyric aciduria, diabetes, and ketoacidosis .

HY-N0717A

D-Valine (R)-Valine	Infection Classification of Application Fields Metabolic Disease Amino acids Endogenous metabolite Disease Research Fields Source Classification	Endogenous Metabolite
D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid.

HY-W007035

H-Val-Ala-OH 1 Publications Verification Valyl-alanine	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Metabolic Disease Endogenous metabolite Disease Research Fields Source Classification	Endogenous Metabolite Amino Acid Derivatives
H-Val-Ala-OH (Valyl-alanine) is a dipeptide formed from L-Valine and L-Alanine residues. H-Val-Ala-OH has a role as a metabolite and also has a bitter taste .

HY-N0717R

L-Valine (Standard) (S)-Valine (Standard)	Structural Classification Human Gut Microbiota Metabolites Microorganisms other families Disease markers Endocrine diseases Amino acids Nervous System Disorder Plants Endogenous metabolite Cancer Source Classification	Reference Standards Arginase Akt Bacterial
L-Valine (Standard) ((S)-Valine (Standard)) is the analytical standard of L-Valine (HY-N0717). This product is intended for research and analytical applications. L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-W016785

Glycyl-L-valine	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Other Diseases Endogenous metabolite Disease Research Fields Source Classification	Biochemical Assay Reagents
Glycyl-L-valine is an organic dipeptide composed of glycine and L-valine .

HY-W007035R

H-Val-Ala-OH (Standard) Valyl-alanine (Standard)	Structural Classification Ketones, Aldehydes, Acids Endogenous metabolite Source Classification	Reference Standards Endogenous Metabolite Amino Acid Derivatives
H-Val-Ala-OH (Valyl-alanine) is a dipeptide formed from L-Valine and L-Alanine residues. H-Val-Ala-OH has a role as a metabolite and also has a bitter taste .

HY-N0717AR

*D-Valine* (Standard)** (R)-Valine (Standard)	Structural Classification Amino acids Endogenous metabolite Source Classification	Reference Standards Endogenous Metabolite
D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid.

HY-113126R

3-Hydroxyisobutyric acid (Standard)	Structural Classification Ketones, Aldehydes, Acids Endogenous metabolite Source Classification	Endogenous Metabolite ATP Synthase Reference Standards
3-Hydroxyisobutyric acid (Standard) is the analytical standard of 3-Hydroxyisobutyric acid. This product is intended for research and analytical applications. 3-Hydroxyisobutyric acid is an important interorgan metabolite, an intermediate in the pathways of l-valine and thymine and a good gluconeogenic substrate.

HY-W016785R

*Glycyl-L-valine* (Standard)**	Structural Classification Ketones, Aldehydes, Acids Endogenous metabolite Source Classification	Reference Standards Endogenous Metabolite
Glycyl-L-valine is a dipeptide that contains glycine and valine.

Cat. No.	Product Name	Chemical Structure

HY-I1124

L-Valine-d8 1 Publications Verification
L-Valine-d₈ is a deuterated form of L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S6

L-Valine-13C5

L-Valine- ¹³C₅ ((S)-Valine- ¹³C₅) is the ¹³C-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S4

L-Valine-1-13C

L-Valine-1- ¹³C ((S)-Valine-1- ¹³C) is the ¹³C-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S

L-Valine-15N

L-Valine- ¹⁵N ((S)-Valine- ¹⁵N) is the ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S1

L-Valine-13C5,15N

L-Valine- ¹³C₅, ¹⁵N ((S)-Valine- ¹³C₅, ¹⁵) is the ¹³C- and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717AS

*D-Valine-d8*
D-Valine-d₈ is the deuterium labeled D-Valine. D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid.

HY-I1111S

Fmoc-L-Val-OH-d8
Fmoc-L-Val-OH-d₈ is a deuterium labeled Fmoc-L-Val-OH (HY-I1111). Fmoc-L-Val-OH is a kind of protect amino acids .

HY-I1111S2

Fmoc-L-Val-OH-13C5,15N
Fmoc-L-Val-OH- ¹³C₅, ¹⁵N is a ¹⁵N-labeled and ¹³C-labled Fmoc-L-Val-OH (HY-I1111). Fmoc-L-Val-OH is a valine derivative .

HY-W002300S

*Boc-L-Valine-d8*
Boc-L-Valine-d₈ is the deuterium labeled Boc-L-Valine .

HY-178305S

L-Valine-d
L-Valine-d is the deuterium labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S8

L-Valine-d1

L-Valine-d₁ ((S)-Valine-d₁) is the deuterium labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S5

L-Valine-2-13C

L-Valine-2- ¹³C ((S)-Valine-2- ¹³C) is the ¹³C-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S9

L-Valine-15N,d8

L-Valine- ¹⁵N,d₈ ((S)-Valine- ¹⁵N,d₈) is the deuterium and ¹⁵N labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S7

L-Valine-1-13C,15N

L-Valine-1- ¹³C, ¹⁵N ((S)-Valine-1- ¹³C, ¹⁵N) is the ¹³C- and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S2

L-Valine-13C5,15N,d8

L-Valine- ¹³C₅, ¹⁵N,d₈ ((S)-Valine- ¹³C₅, ¹⁵N,d₈) is the deuterium, ¹³C-, and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-N0717S3

L-Valine-13C5,15N,d2

L-Valine- ¹³C₅, ¹⁵N,d₂ ((S)-Valine- ¹³C₅, ¹⁵N,d₂) is the deuterium, ¹³C-, and ¹⁵N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-I1111S4

Fmoc-L-Val-OH-15N
Fmoc-L-Val-OH- ¹⁵N is a ¹⁵N-labeled Fmoc-L-Val-OH (HY-I1111). Fmoc-L-Val-OH is a valine derivative .

HY-I1111S1

Fmoc-L-Val-OH-1-13C
Fmoc-L-Val-OH-1- ¹³C is a ¹³C-labeled Fmoc-L-Val-OH (HY-I1111). Fmoc-L-Val-OH is a valine derivative .

HY-178304S

L-Valine-d7
L-Valine-d₇ is the deuterium labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-I1111S3

Fmoc-L-Val-OH-13C5
Fmoc-L-Val-OH- ¹³C₅ is a ¹³C-labeled Fmoc-L-Val-OH (HY-I1111). Fmoc-L-Val-OH is a valine derivative .

HY-W007035S

H-Val-Ala-OH-13C5,15N TFA
H-Val-Ala-OH- ¹³C₅, ¹⁵N (Valyl-alanine- ¹³C₅, ¹⁵N) TFA is the ¹³C- and ¹⁵N-labeled H-Val-Ala-OH (HY-W007035). H-Val-Ala-OH (Valyl-alanine) is a dipeptide formed from L-Valine and L-Alanine residues. H-Val-Ala-OH has a role as a metabolite and also has a bitter taste .

HY-W002300S1

*Boc-L-Valine-15N*
Boc-L-Valine- ¹⁵N is the ¹⁵N-labeled Boc-L-Valine (HY-W002300). Boc-L-Valine is a valine derivative .

HY-143790S

*N-2-(Hydroxyethyl)-L-valine-d4*
N-2-(Hydroxyethyl)-L-valine-d₄ is the deuterium labeled N-2-(Hydroxyethyl)-L-valine .

HY-W142823S

*N-(3-Indolylacetyl)-L-valine-d4*
N-(3-Indolylacetyl)-L-valine-d₄ is deuterium labeled N-(3-Indolylacetyl)-L-valine .

HY-W016785S

*Glycyl-L-valine-13C5,15N TFA*
Glycyl-L-valine- ¹³C₅, ¹⁵N TFA is the ¹³C- and ¹⁵N-labeled Glycyl-L-valine (HY-W016785). Glycyl-L-valine is a dipeptide that contains glycine and valine .

Cat. No.	Product Name		Classification

HY-N0717

*L-Valine* 5 Publications Verification (S)-Valine		Freeze-drying Protective Agents Solubilizing Agents
L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

L-Valine

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

NaturalProducts

Isotope-Labeled Compounds

Oligonucleotides

Natural
Products